Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
28,045
Sort by:
Epidermolysis Bullosa (EB) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Epidermolysis Bullosa (EB) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...
January 2022
60 pages
Epidermolysis Bullosa - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Epidermolysis Bullosa - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Epithelioid Sarcoma - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Epithelioid Sarcoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Epoetin alfa– Biosimilar Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Epoetin alfa– Biosimilar 2022,” report provides comprehensive insights about 15+ companies and 20+ marketed and pipeline...
January 2022
60 pages
Epstein Barr virus (EBV) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Epstein Barr virus (EBV) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
ERBB 2 receptor antagonists - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 2-3 business days DelveInsight’s, “ERBB 2 receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 20+ companies...
January 2022
80 pages
Erosive Esophagitis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Erosive Esophagitis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Erosive Hand Osteoarthritis - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Erosive Hand Osteoarthritis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...
January 2022
60 pages
Esophageal Achalasia - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Esophageal Achalasia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
Essential Thrombocythemia - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Essential Thrombocythemia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Etanercept– Biosimilar Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Etanercept– Biosimilar 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline dr...
January 2022
60 pages
Exanthema - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Exanthema - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical a...
January 2022
60 pages
Exosomes - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Exosomes - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical an...
January 2022
60 pages
Exosomes - Pipeline Insight, 2022
US$ 2,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Exosomes - Pipeline Insight, 2022” report provides comprehensive insights about 55+ companies and 70+ pipeline d...
January 2022
200 pages
Exportin-1 protein inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Exportin-1 protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 6+...
January 2022
60 pages
Eye Infections - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Eye Infections - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
Eye Neoplasms - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Eye Neoplasms - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historic...
January 2022
60 pages
Facial Lines - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Facial Lines - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...
January 2022
60 pages
Factor Xa inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Factor Xa inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 6+ companies and 6+ pipeline...
January 2022
60 pages
Factor XI inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Factor XI inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 8+ companies and 8+ pipeline...
January 2022
60 pages
Failed Back Surgery Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Failed Back Surgery Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the di...
January 2022
60 pages
Fanconi Anemia - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fanconi Anemia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histori...
January 2022
60 pages
Farber's disease - Epidemiology Insight - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Farber's disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...
January 2022
60 pages
Fecal Incontinence - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fecal Incontinence - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
